Reading Time: 2 minutes Chimeric antigen receptor (CAR) T-cell therapy is an incredibly promising novel immunotherapy for several hematological cancers, especially for patients that have exhausted other treatment options. CAR T works by altering a patient’s own blood to produce artificial, genetically engineered T cell receptors that recognize and eliminate cancerous cells in the body.1 The most common form […]
Article











